James A Schoeneck

CIK 1420987 · Interim President · last filed 2025-08-25

James A Schoeneck is an Interim President who has filed 73 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider bought $150.0K of CLDI on Aug 25, 2025. Across all open-market trades the lifetime net is −$1.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.9K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.9K

Companies

5

Total Filings

73

Lifetime Open-Market Net

-$1.79M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CLDI Director 84,167 $0.15 $12.9K $150.0K 2 2025-08-25
KYNTRA BIO, INC. (FGEN) Delisted Director 68,432 $9.75 $667.2K -$1.20M 28 2025-07-02
Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Director 2,035,668 $0.01 $11.8K $0 6 2024-10-15
ANAB Director $56.07 $0 2 2018-02-06
Assertio Therapeutics, Inc (DEPO) Delisted President and CEO 495,105 -$743.6K 35 2017-02-10

Recent Filings

73 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-08-25 CLDI Buy (P) +75,000 $150.0K EDGAR
2025-07-15 CLDI Grant (A) $0 EDGAR
2025-07-02 KYNTRA BIO, INC. (FGEN) Delisted Buy (P) +23,567 $119.5K EDGAR
2025-06-06 KYNTRA BIO, INC. (FGEN) Delisted Grant (A) $0 EDGAR
2025-03-24 KYNTRA BIO, INC. (FGEN) Delisted Buy (P) +300,000 $105.0K EDGAR
2024-10-15 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Grant (A) $0 EDGAR
2024-07-02 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Grant (A) +79,687 $0 EDGAR
2024-07-02 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Grant (A) +28,207 $0 EDGAR
2024-06-06 KYNTRA BIO, INC. (FGEN) Delisted Grant (A) $0 EDGAR
2024-06-05 Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Mixed +548,000 $109.6K EDGAR
Showing 110 of 73
Page 1 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.